These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9818826)

  • 1. Hearing results of intratympanic steroid treatment of endolymphatic hydrops.
    Arriaga MA; Goldman S
    Laryngoscope; 1998 Nov; 108(11 Pt 1):1682-5. PubMed ID: 9818826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?
    Hillman TM; Arriaga MA; Chen DA
    Laryngoscope; 2003 Nov; 113(11):1903-7. PubMed ID: 14603044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral steroid treatment for hearing improvement in Ménière's disease and endolymphatic hydrops.
    Fisher LM; Derebery MJ; Friedman RA
    Otol Neurotol; 2012 Dec; 33(9):1685-91. PubMed ID: 23047260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
    Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
    Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing results of intratympanic steroid treatment of endolymphatic hydrops.
    Bayazit Y
    Laryngoscope; 2001 Jun; 111(6):1114-5. PubMed ID: 11404633
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease.
    Wick CC; Manzoor NF; McKenna C; Semaan MT; Megerian CA
    Am J Otolaryngol; 2017; 38(3):285-290. PubMed ID: 28214024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
    Martin-Sanz E; Esteban-Sanchez J; Rodrigañez-Riesco L; Sanz-Fernández R
    Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Round Window Niche Drilling with Intratympanic Steroid Is a Salvage Therapy of Sudden Hearing Loss.
    Si Y; Jiang HL; Chen YB; Chu YG; Chen SJ; Chen XM; He WH; Zheng YQ; Zhang ZG
    Audiol Neurootol; 2018; 23(6):309-315. PubMed ID: 30630184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.
    Kara E; Cetik F; Tarkan O; Sürmelioğlu O
    Eur Arch Otorhinolaryngol; 2010 May; 267(5):701-7. PubMed ID: 19862543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratympanic Dexamethasone via Saturated Gelfoam for Idiopathic Sudden Sensorineural Hearing Loss.
    Lundy L; Karatayli Ozgursoy S; Kleindienst S
    Otolaryngol Head Neck Surg; 2019 Feb; 160(2):361-363. PubMed ID: 30511891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss.
    Herr BD; Marzo SJ
    Otolaryngol Head Neck Surg; 2005 Apr; 132(4):527-31. PubMed ID: 15806039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study.
    Liu B; Leng Y; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
    Medicine (Baltimore); 2016 Dec; 95(52):e5767. PubMed ID: 28033296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
    Beyea JA; Instrum RS; Agrawal SK; Parnes LS
    Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report).
    Silverstein H; Choo D; Rosenberg SI; Kuhn J; Seidman M; Stein I
    Ear Nose Throat J; 1996 Aug; 75(8):468-71, 474, 476 passim. PubMed ID: 8828271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear.
    Yoshioka M; Naganawa S; Sone M; Nakata S; Teranishi M; Nakashima T
    Otol Neurotol; 2009 Aug; 30(5):645-8. PubMed ID: 19415042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
    Gouveris H; Selivanova O; Mann W
    Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic steroid perfusion for the treatment of Ménière's disease: a retrospective study.
    Dodson KM; Woodson E; Sismanis A
    Ear Nose Throat J; 2004 Jun; 83(6):394-8. PubMed ID: 15266874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intratympanic corticosteroid perfusion in the therapy of Meniere's disease].
    Sanković-Babić S; Kosanović R; Ivanković Z; Babac S; Tatović M
    Srp Arh Celok Lek; 2014; 142(5-6):291-5. PubMed ID: 25033583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.